Packaging Automation Market Regional Analysis

Global Packaging Automation Market size was valued at USD 68.6 billion in 2023 and is poised to grow from USD 72.58 billion in 2024 to USD 113.94 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The market in packaging automotive is fragmented, with numerous players competing for market share. The key players are collaborating and together developing to drive the market growth. For businesses that produce lower numbers of goods, a sorting system is frequently necessary throughout the packing process. Artificial intelligence (Al) algorithms are used in robotic sorting systems along with scanning apparatus like barcode scanners. As a result, packaging efficiency increases and sorting is accelerated. In order to provide speedy sorting for secondary or tertiary packing, startups are creating "turn-key" robots. Several startups are making investments in upgrading their factories to increase output, efficiency, and productivity. 'Multivac Group (Germany) ', 'Coesia SpA (Italy) ', 'ULMA Packaging (Spain) ', 'Syntegon Technology (Germany) ', 'Swisslog Healthcare (Switzerland) ', 'Rockwell Automation Inc. (USA) ', 'Sealed Air Corporation (USA) ', 'Mitsubishi Electric Corporation (Japan) ', 'Automated Packaging Systems LLC (USA) ', 'IMA Industria Macchine Automatiche (Italy) ', 'Krones AG (Germany) ', 'WestRock Company (USA) ', 'Winpak Ltd. (Canada) ', 'J.S. Corrugating Machinery Co. Ltd (China) ', 'Poongsan Holdings Corporation (South Korea) ', 'Cermex (France) ', 'SIG Group (Switzerland) ', 'Tetra Pak (Switzerland) ', 'Bosch Packaging Technology (Germany) ', 'Sidel Group (France)'

Since so many people now view online shopping as the new baseline, one of the most popular trends now is electronic commerce. Online shopping is growing significantly in emerging economies like China and India. Due to the growing e-commerce industry, there is a significant need for packaging equipment at all stages of e-commerce manufacturing, including primary and secondary packing, labelling, and product tagging and marking. Additionally, product packaging has a big influence on customers' purchase behavior since it helps keep products safe and separates brands using eye-catching and creative images.

The pharmaceutical industry has gone through significant disruption as a consequence of COVID 19, and there have been numerous technological advancements. The industry has adopted digital supply chain management systems as a result of significant factors that have raised the value and complexity of the supply chain ecosystem. As an illustration, the development of novel techniques for vaccines and biologics demands the use of specialized materials, the maintenance of specific temperature ranges, and the requirement for visibility and transparency. According to The Association for Packaging and Processing Technologies, the development of injectables and personalized pharmaceuticals is causing manufacturers to rethink their manufacturing and packaging strategies as drug companies see a fundamental shift in product forms. Manufacturers are attempting to use the potential of digital data to boost operational efficiency. A recent FDA News investigation found that over 80% of the found disparities might be attributed to human error. Additionally, the demand for small batch manufacturing is growing because only 28% of the pharmaceutical industry's profits in the United States come from generic prescriptions. Packaging automation can assist you in achieving consistent quality even when producing batches. The adoption of industry 4.0 has greatly advanced the pharmaceutical industry. By enabling continuous process control across all processes, including packing, it minimizes human interaction while providing analytical insights and enabling the capability to make quicker decisions as necessary. Additionally, due to the declining cost of robotics systems like parallel robots and arms robots, which offer automation with sustainability and flexibility, pharmaceutical businesses are beginning to recognize the financial benefits of robotics components over outdated machinery.

All through the forecast period, North America is expected to dominate the market. Because there are already so many leading pharmaceutical businesses on the market, drug development and genomics are receiving a lot of attention and funding. In the United States, there is almost a third of the global biopharmaceutical market. According to the Pharmaceutical Research and Manufacturers Association, US corporations invest $75 billion annually in pharmaceutical R&D, or half of all such investment worldwide (PhRMA). Additionally, the domestic barriers to entry into the pharmaceutical market in the United States are some of the lowest in the world, making it one of the most favorable domestic environments for pharmaceutical R&D and commercialization.